# Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

> **NCT07217704** · PHASE3 · RECRUITING · sponsor: **SOFIE** · enrollment: 200 (estimated)

## Conditions studied

- Esophageal Cancer
- Gastric Cancer (GC)
- Gastroesophageal Junction

## Interventions

- **DRUG:** [18F]FAPI-74 PET/CT

## Key facts

- **NCT ID:** NCT07217704
- **Lead sponsor:** SOFIE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-14
- **Primary completion:** 2027-08-30
- **Final completion:** 2027-08-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07217704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07217704, "Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07217704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*